IFNL3 and Hepatitis: Although IL28B SNPs have been shown to predict SVR in patients with chronic hepatitis C and correlate with hepatitis activity in CHB [4,25–27], there was no correlation between IL28B SNPs and SVR in both HBeAg-positive and HBeAg-negative patients.